SunTrust Upgrades Abaxis (ABAX) to Buy

March 10, 2009 10:29 AM EDT

SunTrust upgrades Abaxis (Nasdaq: ABAX) from Neutral to Buy. Price target $21.

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems for use in any human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements.


Related Categories

Upgrades

Stocks Mentioned

ABAX 23.59

+0.75 +3.28%
Volume: 96,997
Track ABAX


Add Your Comment